{"BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$88 to $77"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$95 to $93"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$88 to $91"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$90 to $91"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$99 to $96"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$110 to $105"}, {"Date": "2022-02-18", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$98 to $95"}, {"Date": "2022-02-11", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$91"}, {"Date": "2022-01-07", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$86 to $110"}, {"Date": "2022-01-07", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$101"}], "Score": 1.36, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 11, "Period": "180 days", "Analists": ["Citigroup", "KeyBanc Capital Markets", "Morgan Stanley", "Stifel", "Wells Fargo", "Raymond James", "BofA Securities", "UBS", "Goldman"], "Price_Target": 95.45}, "HOLX": {"Ticker": "HOLX", "Company": "Hologic", "Sector": "Health Care", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$80"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Evercore ISI"], "Price_Target": 80.0}, "PPL": {"Ticker": "PPL", "Company": "PPL", "Sector": "Utilities", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-03-09", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$28 to $30"}, {"Date": "2022-02-22", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$32 to $31"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Wolfe Research", "RBC Capital Mkts", "Argus"], "Price_Target": 19.33}, "DGX": {"Ticker": "DGX", "Company": "Quest Diagnostics", "Sector": "Health Care", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$175 to $140"}, {"Date": "2022-02-23", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$160 to $139"}, {"Date": "2022-02-02", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$135"}, {"Date": "2022-01-28", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$190 to $129"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Jefferies", "Deutsche Bank", "Citigroup", "UBS"], "Price_Target": 135.75}, "WELL": {"Ticker": "WELL", "Company": "Welltower", "Sector": "Real Estate", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Upgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Perform to Sector Outperform", "Target_Change": "$110"}, {"Date": "2022-02-01", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$92"}, {"Date": "2022-01-20", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$68 to $94"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Scotiabank", "Credit Suisse", "Mizuho"], "Price_Target": 98.67}, "ZBRA": {"Ticker": "ZBRA", "Company": "Zebra Technologies", "Sector": "Information Technology", "Updated": "2022-04-04", "Rating": [{"Date": "2022-04-04", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$530 to $500"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["JP Morgan"], "Price_Target": 500.0}}